Rationale for GLP-1RA Use in Alzheimers Disease Neuroinflammation and neuroimmune dysfunction are increasingly recognized as key contributors to AD pathophysiology, particularly in early disease stages
The new agreements are in effect until March 31, 2023 Lexaria Granted Important New Oral Nicotine Patent March 08, 2022 Newest granted patent expands worldwide patent portfolio to 24 Lexaria Reports Potentially Ground Breaking Findings in Sildenafil Animal Study February 2, 2022 DehydraTECH sildenafil delivered 74% more drug at 4 minutes, than the control Lexarias DehydraTECH-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2 December 8, 2021 Testing confirms that DehydraTECH-processed cannabidiol reduces arterial stiffness, potentially broadening application to treatment of cardiovascular and other diseases beyond hypertension
was supported by a Research Development Award from the Muscular Dystrophy Association
What to do if you miss a dose of Ozempic
The difference between semaglutide and tirzepatide, besides the fact that one is a single-hormone and the other is a dual-hormone agonist, is how effective they are, Anekwe said
Some providers explore microdosing tirzepatide because its broader mechanism may allow for enhanced benefits at lower doses